Cardioplegia Solution IV Bags Recalled for Sterility Assurance Deficiency
Central Admixture Pharmacy Services is recalling Cardioplegia Solution IV bags (Lot 36-257024) due to lack of sterility assurance and insufficient validation of decontamination processes. Healthcare providers should discontinue use immediately.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The product is classified as FDA Class II. While no illnesses or injuries have been reported, the lack of sterility assurance and inadequate validation of decontamination cycles in an intravenous cardiac medication represents a risk-of-harm product without yet-reported injury, meeting the criteria for High severity.
Plain-English summary
Central Admixture Pharmacy Services, Inc. is recalling 48 bags of Cardioplegia Solution, IV Bag (Total Volume 1818 mL, Crystalloid Induction formulation, NDC 72196-0216-1, Lot 36-257024) that were distributed nationwide. The recall was initiated due to a lack of assurance of sterility and insufficient validation data for decontamination cycles.
Cardioplegia solution is administered intravenously during cardiac surgery to protect the heart during the procedure. The deficiencies in sterility assurance and decontamination validation create a potential risk of microbial contamination in the product.
Healthcare providers and hospitals that received the affected lot (36-257024, expiration 8/14/2023) should immediately discontinue use and contact Central Admixture Pharmacy Services, Inc. at their facility in Phoenix, Arizona for instructions on product return or replacement. Any adverse events associated with use of this product should be reported to the FDA.
The recalled product
- Product
- CARDIOPLEGIA SOLUTION, IV Bag, Total Volume = 1818 mL, CRYSTALLOID INDUCTION, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0216-1
- Manufacturer
- Central Admixture Pharmacy Services, Inc.
- Category
- Drug — Intravenous / Surgical
- Hazard
- sterility
- validation-failure
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: 36-257024
- Exp. 8/14/2023.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27